Equity
GEBOCO has made a profit without a break since 2016.
GEBOCO has made a profit without a break since 2016.
The micro format states no turnover.
Green is investment, beige is depreciation. Land and buildings stand 20.3% higher than in 2024.
Short-term debts rose from €169,461 to €251,261.
Five of the last ten came late. The 2022 accounts came in latest, 30 days after the end of the period.
More equity than 91% of companies in head offices and management consultancy. The sector median is €79,356, over 41,355 companies.
In July 2024, 14,780 companies had the same profile as GEBOCO has now. Each dot stands for 37 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.4% | 0.5% |
| 3 | 0.6% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.4% | 1.6% |
| 7 | 1.7% | 1.8% |
| 8 | 1.9% | 2.0% |
| 9 | 3.1% | 3.3% |
| 10 | 5.9% | 6.4% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,780 companies, not a prediction for GEBOCO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| GEBOCO Wingene | €0.9m | €93,346 | 69.0% | - |
| DE LEENHEER J. Roeselare | €0.9m | €87,740 | 96.3% | - |
| SAMANCO Oostkamp | €0.9m | €101,751 | 88.4% | - |
| Mathis Pharma Bruges | €1.1m | €94,444 | 52.8% | - |
| Passer Bruges | €0.8m | €97,878 | 65.5% | - |
| T@C - TEX Waregem | €1.1m | €86,982 | 55.9% | - |
| WODL Knokke-Heist | €0.9m | €114,509 | 70.4% | - |
These companies have the same main activity as GEBOCO: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €788,000 and €1.1m, founded between 2003 and 2006.
GEBOCO files the micro format. That format states no turnover. The gross margin rose from €69,369 in 2006 to €93,346 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.